ACST

Acasti Pharma, Inc.

3.21 USD
-0.13 (-3.89%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Acasti Pharma, Inc. stock is up 32.1% since 30 days ago. The next earnings date is Jun 21, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 11 February’s closed higher than January. 100% of analysts rate it a buy.

About Acasti Pharma, Inc.

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre, an omega-3 phospholipid therapeutic to treat patients with hypertriglyceridemia.